Breast cancer can be categorized into molecular subtypes by genetic information including the status of estrogen receptor (ER) and progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) (1). This evidence concerns the gene ERBB2 and breast carcinoma.